Patents/Assignees

SANTEN PHARMACEUTICAL CO., Ltd.

12 patents in portfolio

US12510536utility2025
Method for Changing Condition of Eyelid of Hairless Animal
0 cites
US12295946utility2025
Pharmaceutical Formulations Comprising a Pyridylaminoacetic Acid Compound
0 cites
US12290497utility2025
Agent Containing 4-phenylbutyrate, for Preventing or Treating Presbyopia
0 cites
US12290511utility2025
Pharmaceutical Preparation Containing Pyridyl Aminoacetic Acid Compound
0 cites
US12201602utility2025
Medicament Comprising Combination of Sepetaprost and Rho-associated Coiled-coil Containing Protein Kinase Inhibitor
0 cites
US11974994utility2024
Agent for Treating or Preventing Glaucoma Including a Sulfonamide Compound and Another Drug
0 cites
US11951098utility2024
Therapeutic Agent for Meibomian Dysfunction
0 cites
US11872271utility2024
High-affinity Anti-vegf Antibody Klha505
0 cites
US11793798utility2023
Pharmaceutical Formulations Comprising a Pyridylaminoacetic Acid Compound
0 cites
US11666563utility2023
Pharmaceutical Preparation Containing Pyridyl Aminoacetic Acid Compound
0 cites
US11642350utility2023
Agent for Preventing Myopia, Treating Myopia, And/or Preventing Myopia Progression Comprising Tiotropium as Active Ingredient
0 cites
US11612590utility2023
Therapeutic Agent for Meibomian Dysfunction
0 cites